These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17620)

  • 21. Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
    Santoro SA; Cowan JF
    Biochim Biophys Acta; 1984 Feb; 797(2):178-85. PubMed ID: 6607747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of vancomycin on ristocetin and bovine PAF-induced agglutination of human platelets.
    Baugh RF; Jacoby C; Brown JE; Hougie C
    Thromb Res; 1978 Mar; 12(3):511-21. PubMed ID: 306689
    [No Abstract]   [Full Text] [Related]  

  • 23. Localization of von Willebrand factor and thrombin-interactive domains on human platelet glycoprotein Ib.
    Katagiri Y; Hayashi Y; Yamamoto K; Tanoue K; Kosaki G; Yamazaki H
    Thromb Haemost; 1990 Feb; 63(1):122-6. PubMed ID: 2339348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pH dependence of quantitative ristocetin-induced platelet aggregation: theoretical and practical implications-a new device for maintenance of platelet-rich plasma pH.
    Coller BS; Franza BR; Gralnick HR
    Blood; 1976 May; 47(5):841-54. PubMed ID: 4176
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet-binding of the von Willebrand factor.
    Green D; Muller HP
    Thromb Haemost; 1978 Jun; 39(3):689-94. PubMed ID: 309191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of factor VIII-von Willebrand factor ristocetin cofactor activity by monoclonal antibodies.
    Hornsey V; Micklem LR; McCann MC; James K; Dawes J; McClelland DB; Prowse CV
    Thromb Haemost; 1985 Aug; 54(2):510-4. PubMed ID: 3878608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Family studies of patients with reduced ristocetin aggregation and abnormalities of factor VIII and/or platelet function.
    Ekert H; Ananthakrishnan R; Muntz RH; Dowling S; D'Souza S
    Thromb Haemost; 1976 Aug; 36(1):78-85. PubMed ID: 1087478
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
    Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
    J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of frozen thrombocytes for the determination of von willebrand factor with the aid of ristocetin].
    Caduff T; Straub PW
    Schweiz Med Wochenschr; 1979 Mar; 109(11):399-402. PubMed ID: 34214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Variations in quantitative ristocetin platelet aggregation (RPA) with time after platelet rich plasma (PRP) preparation: association with alteration in pH.
    Coller BS; Gralnick HR
    Thromb Diath Haemorrh; 1975 Nov; 34(2):581-2. PubMed ID: 809
    [No Abstract]   [Full Text] [Related]  

  • 33. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets.
    Scott JP; Montgomery RR; Retzinger GS
    J Biol Chem; 1991 May; 266(13):8149-55. PubMed ID: 2022635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vancomycin effect on thrombin-induced platelet aggregation: evidence against a common platelet membrane receptor for thrombin and ristocetin.
    Weinger RS; Moake JL
    Thromb Res; 1978 May; 12(5):911-15. PubMed ID: 307833
    [No Abstract]   [Full Text] [Related]  

  • 35. Cleavage of rhamnose from ristocetin A removes its ability to induce platelet aggregation.
    Bardsley B; Williams DH; Baglin TP
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):241-4. PubMed ID: 9663706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ristocetin-induced platelet agglutination in four Chinese patients with Glanzmann's thrombasthenia.
    Joyce RP; Ho FC; Hui PK; Wong HW; Lai MP
    Pathology; 1985 Jan; 17(1):71-4. PubMed ID: 4000715
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vancomycin as well as ristocetin facilitates von Willebrand factor binding to platelets.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jul 1-15; 19(1-2):287-92. PubMed ID: 6969463
    [No Abstract]   [Full Text] [Related]  

  • 38. Actinoidin: a new inhibitor of ristocetin- and ristomycin-induced platelet agglutination.
    Boda Z; Solum NO; Sztaricskai F; Rak K
    Thromb Res; 1980 Mar; 17(5):603-10. PubMed ID: 6247776
    [No Abstract]   [Full Text] [Related]  

  • 39. The agglutination of human platelets by bovine factor VIII: R.
    Kirby EP
    J Lab Clin Med; 1982 Dec; 100(6):963-76. PubMed ID: 6183384
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Further studies of the interaction between ristocetin and fibrinogen.
    Goh AT; Firkin BG
    Haemostasis; 1976; 5(2):57-65. PubMed ID: 950175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.